MAR Research Update — July 20, 2026
Updated Thesis
Marriott International is a global asset-light hotel franchisor, manager and licensor whose high-quality brands, nearly 283 million Bonvoy members, more than 9,900 properties across 146 countries and record 4,107-property development pipeline create meaningful network, distribution and brand advantages. Q1 2026 demonstrated resilient underlying fee economics: adjusted revenue excluding cost-reimbursement pass-throughs rose 13%, gross fee revenue increased 12% to $1.433 billion, and net rooms grew 4.5%, although reported revenue growth was 6.2% in the most recent quarter and earnings growth was negative 2.6% in the most recent quarter. The business is attractive but cyclical and financially aggressive, with $16.53 billion of debt, only $454 million of cash and a negative 74.1% ROE driven partly by buybacks.
The investment grade as of this refresh is C — average business quality. Medium-tier business, expensive-tier valuation; 3.4% downside to $353.64 fair value.
Grade Change
In this research cycle, the investment grade for Marriott International, Inc. moved from D to C. Medium-tier business, expensive-tier valuation; 3.4% downside to $353.64 fair value.
Key Metrics at a Glance
- Revenue growth: +6.2% year over year
- Net margin: 9.7%
- Fair value upside: -3.4% to our estimate of $354
Current price: $366.24
These figures reflect our most recent data pull and are one input into a multi-factor valuation framework.
Our 12–18 Month Outlook
Quality companies held over a multi-year horizon benefit from compounding fundamentals and the patience to ride through short-term volatility. Marriott International, Inc. remains in our covered universe with a average-quality assessment. We update research when material data changes — earnings revisions, management shifts, or regime changes in valuation — not on every price fluctuation.
Long-term accumulation of quality businesses at fair or better prices is the core of the Patient Accumulator approach. Research updates like this one inform whether to add, hold, or wait for a better zone — not whether to react to short-term price moves.
[View full MAR research →](/stocks/MAR)